| Literature DB >> 20107863 |
Anja Wilmes1, Pisana Rawson, Lifeng Peng, Danyl McLauchlan, Peter T Northcote, T William Jordan, John H Miller.
Abstract
Peloruside A, isolated from the marine sponge Mycale hentscheli, has a similar mechanism of action to paclitaxel (Taxol®), a drug used clinically to treat tumors of the breast, ovary and lung. Paclitaxel and peloruside stabilize the polymerized form of tubulin and arrest cells in G₂/M of the cell cycle. We have therefore used two-dimensional electrophoresis of proteins to examine the effect of peloruside A on the human HL-60 promyeloid leukemic cell line. Our goals included investigation whether affected proteins could be mapped onto pathways that predicted the cellular effects of this compound. In response to 100 nM peloruside A treatment for 24 h, seventeen identified proteins showed significant change in abundance with fourteen increases and three decreases. Use of Ingenuity Pathways Analysis confirmed that peloruside A affected pathways consistent with the known effects on microtubules and apoptosis. Our results also indicate a potential role of c-Myc in the cellular actions of peloruside consistent with an induction of aneuploidy seen at low concentrations of peloruside.Entities:
Mesh:
Substances:
Year: 2010 PMID: 20107863 DOI: 10.1007/s10637-010-9387-5
Source DB: PubMed Journal: Invest New Drugs ISSN: 0167-6997 Impact factor: 3.850